Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT

Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen and Penelope Ward
Journal of Nuclear Medicine October 2017, 58 (10) 1596-1602; DOI: https://doi.org/10.2967/jnumed.116.188375
Matthew P. Miller
1Blue Earth Diagnostics (BED), Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lale Kostakoglu
2Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Pryma
3Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Qin Yu
4Fox Chase Cancer Center, Philadelphia, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Chau
1Blue Earth Diagnostics (BED), Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Perlman
5American College of Radiology, Philadelphia, Pennsylvania; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonnie Clarke
6Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network, Reston, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Rosen
5American College of Radiology, Philadelphia, Pennsylvania; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penelope Ward
1Blue Earth Diagnostics (BED), Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 10 1596-1602
DOI 
https://doi.org/10.2967/jnumed.116.188375
PubMed 
28385791

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication December 8, 2016
  • Accepted for publication March 22, 2017
  • Published online October 2, 2017.

Article Versions

  • previous version (April 6, 2017 - 05:47).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Matthew P. Miller1,
  2. Lale Kostakoglu2,
  3. Daniel Pryma3,
  4. Jian Qin Yu4,
  5. Albert Chau1,
  6. Eric Perlman5,
  7. Bonnie Clarke6,
  8. Donald Rosen5 and
  9. Penelope Ward1
  1. 1Blue Earth Diagnostics (BED), Oxford, United Kingdom
  2. 2Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
  3. 3Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  4. 4Fox Chase Cancer Center, Philadelphia, Pennsylvania
  5. 5American College of Radiology, Philadelphia, Pennsylvania; and
  6. 6Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network, Reston, Virginia
  1. For correspondence or reprints contact: Matthew P. Miller, Blue Earth Diagnostics Ltd., The Oxford Science Park, Oxford, OX4 4GA U.K. E-mail: m.miller{at}blueearthdx.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 30 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
    Wolfgang P. Fendler, Jeremie Calais, Matthias Eiber, Robert R. Flavell, Ashley Mishoe, Felix Y. Feng, Hao G. Nguyen, Robert E. Reiter, Matthew B. Rettig, Shozo Okamoto, Louise Emmett, Helle D. Zacho, Harun Ilhan, Axel Wetter, Christoph Rischpler, Heiko Schoder, Irene A. Burger, Jeannine Gartmann, Raven Smith, Eric J. Small, Roger Slavik, Peter R. Carroll, Ken Herrmann, Johannes Czernin, Thomas A. Hope
    JAMA Oncology 2019 5 6
  • 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
    Jeremie Calais, Francesco Ceci, Matthias Eiber, Thomas A Hope, Michael S Hofman, Christoph Rischpler, Tore Bach-Gansmo, Cristina Nanni, Bital Savir-Baruch, David Elashoff, Tristan Grogan, Magnus Dahlbom, Roger Slavik, Jeannine Gartmann, Kathleen Nguyen, Vincent Lok, Hossein Jadvar, Amar U Kishan, Matthew B Rettig, Robert E Reiter, Wolfgang P Fendler, Johannes Czernin
    The Lancet Oncology 2019 20 9
  • A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT
    Birgit Pernthaler, Roman Kulnik, Christian Gstettner, Spela Salamon, Reingard M. Aigner, Herbert Kvaternik
    Clinical Nuclear Medicine 2019 44 10
  • Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial
    Andrew F. Scarsbrook, David Bottomley, Eugene J. Teoh, Kevin M. Bradley, Heather Payne, Asim Afaq, Jamshed Bomanji, Nicholas van As, Sue Chua, Peter Hoskin, Anthony Chambers, Gary J. Cook, Victoria S. Warbey, Sai Han, Hing Y. Leung, Albert Chau, Matthew P. Miller, Fergus V. Gleeson, Gerard Andrade, Philip Camilieri, Katherine Hyde, Ruth Macpherson, Neel Patel, Ami Sabharwal, Manil Subesinghe, Maria Tsakok
    International Journal of Radiation Oncology*Biology*Physics 2020 107 2
  • The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Rang Wang, Guohua Shen, Mingxing Huang, Rong Tian
    Frontiers in Oncology 2021 11
  • 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment
    Joseph R. England, Jeremy Paluch, Leslie K. Ballas, Hossein Jadvar
    Clinical Nuclear Medicine 2019 44 3
  • Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation
    Eugene J Teoh, Daniel R McGowan, David M Schuster, Maria T Tsakok, Fergus V Gleeson, Kevin M Bradley
    The British Journal of Radiology 2018 91 1085
  • Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria
    Emre Demirci, Reşit Akyel, Biray Caner, Nalan Alan-Selçuk, Şermin Güven-Meşe, Meltem Ocak, Levent Kabasakal
    Nuclear Medicine Communications 2020 41 8
  • Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
    Xu Bin, Shan Yong, Qing-Fang Kong, Sun Zhao, Guang-Yuan Zhang, Jian-Ping Wu, Shu-Qiu Chen, Wei-Dong Zhu, Ke-Hao Pan, Mu-Long Du, Ming Chen
    Frontiers in Oncology 2020 9
  • Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-Prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial
    Grant Harmon, Dennis Chan, Brian Lee, Chelsea Miller, Alex Gorbonos, Gopal Gupta, Marcus Quek, Michael Woods, Bital Savir-Baruch, Matthew M. Harkenrider, Abhishek A. Solanki
    International Journal of Radiation Oncology*Biology*Physics 2021 111 5

Article usage

Article usage: April 2017 to April 2025

AbstractFullPdf
Apr 2017400046
May 2017343067
Jun 201777020
Jul 201765015
Aug 201752018
Sep 201771018
Oct 201711321289
Nov 20172931338
Dec 2017941016
Jan 2018109427
Feb 2018961222
Mar 201855517
Apr 2018743128
May 2018351118
Jun 2018261616
Jul 2018302019
Aug 20181375
Sep 2018371219
Oct 2018252620
Nov 2018261214
Dec 2018191112
Jan 2019241125
Feb 2019341831
Mar 201920817
Apr 2019241113
May 2019231018
Jun 2019281518
Jul 201935822
Aug 201913413
Sep 201913920
Oct 2019141817
Nov 201913922
Dec 201914615
Jan 202015315
Feb 2020958
Mar 2020161216
Apr 202021813
May 2020181120
Jun 2020201214
Jul 202022813
Aug 2020151212
Sep 202027155
Oct 2020231519
Nov 202023716
Dec 20207168
Jan 2021102118
Feb 2021113722
Mar 2021166513
Apr 202143017
May 202163415
Jun 2021131011
Jul 202141215
Aug 202181413
Sep 20216186
Oct 2021111627
Nov 202131423
Dec 202141823
Jan 202241318
Feb 20221188
Mar 202231812
Apr 2022677
May 202281412
Jun 202251114
Jul 20221237
Aug 20220169
Sep 202231717
Oct 20221164
Nov 20224123
Dec 20224112
Jan 202342915
Feb 20233139
Mar 20233263
Apr 2023278
May 202321511
Jun 20232118
Jul 2023676
Aug 2023357
Sep 2023542
Oct 2023388
Nov 202332210
Dec 202313174
Jan 20246147
Feb 20245813
Mar 20243328
Apr 202451713
May 20240253
Jun 20247188
Jul 202461313
Aug 20242269
Sep 202401811
Oct 202452016
Nov 202451110
Dec 20240134
Jan 202501111
Feb 202555210
Mar 2025312224
Apr 202563434
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (10)
Journal of Nuclear Medicine
Vol. 58, Issue 10
October 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen, Penelope Ward
Journal of Nuclear Medicine Oct 2017, 58 (10) 1596-1602; DOI: 10.2967/jnumed.116.188375

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen, Penelope Ward
Journal of Nuclear Medicine Oct 2017, 58 (10) 1596-1602; DOI: 10.2967/jnumed.116.188375
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • The Effect of Including Bone in Dixon-Based Attenuation Correction for 18F-Fluciclovine PET/MRI of Prostate Cancer
  • Google Scholar

More in this TOC Section

Oncology

  • Comparative PSMA expression at early (1hour) vs late (2hour) in primary and secondary sites of involvement in prostate cancer.
  • Imaging spectrum of peritoneal carcinomatosis associated with various etiologies on 18F-FDG PET/CT
  • Diagnostic Role of 18F-FDG PET/CT in Urothelial carcinoma and its impact on management, and prognosis : A case based approach
Show more Oncology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • PET/CT
  • 18F-FACBC
  • prostate cancer
  • 18F-fluciclovine
SNMMI

© 2025 SNMMI

Powered by HighWire